SwecureImproving quality of life

“The company is working to reduce the prevalence of allergies and to improve the quality of life for mankind.”

swecure_4

swecure_2

swecure_3

swecure_5

About Swecure

Swecure is based on prominent research from Sahlgrenska University Hospital. The company runs a number of parallel projects, with common denominator in the effect of the intestinal flora for various diseases. The projects are in the preclinical phase and the company holds both approved patents as well as patent applications that have not yet been approved.

Swecures product portfolio includes a new treatment for the chronic inflammatory gut disease IBD and a treatment for IBS. The company also developes additional forms of treatment including allergy prevention. The prevalence of allergic diseases have increased dramatically lately, primary due to the past 50 years of major hygienic lifestyle changes. The prevalence of a number of chronically medical conditions, including IBD and allergy, has increased significantly during the past decades. Current treatments are primarily aimed at relieving symptoms and are linked to high costs. The market is therefore in need of cheaper, more efficient but also more gentle treatments.

Contact

DSC_4964-3

ARVID GILLJAM
Business Developer

+46 70 791 3464
arvid@swecure.com

Swecure
Stureplan 15
SE-11145 Stockholm
Sweden

www.swecure.com
info@swecure.com

swecure-logo-grey